Cognitive dysfunction and antiphospholipid antibodies

  • Simone Appenzeller
  • , Aline Tamires Lapa
  • , Jozélio Freire De Carvalho
  • , Fernando Augusto Peres
  • , Yehuda Shoenfeld*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Antiphospholipid syndrome (APS) is a multisystem prothrombotic condition, however, in recent years, its inflammatory nature has been studied extensively. Cerebral involvement is commonly observed in APS and results in different clinical manifestations. However, most of the studies include secondary APS. In this article, we review the prevalence, clinical characteristics, and physiopathology of cognitive impairment in patients with primary APS.

Original languageEnglish
Pages (from-to)95-98
Number of pages4
JournalCurrent Rheumatology Reports
Volume14
Issue number1
DOIs
StatePublished - Feb 2012
Externally publishedYes

Funding

FundersFunder number
Conselho Nacional Pesquisa Desenvolvimento-Brasil CNPq300447/2009-4
Federico and Elvia Faggin Foundation
Fundação de Amparo à Pesquisa do Estado de São Paulo2009/06049-6, 2008/ 02917-0
Fundação de Apoio à Pesquisa do Estado da Paraíba

    Keywords

    • Anticardiolipin antibodies
    • Antiphospholipid antibodies
    • Antiphospholipid syndrome
    • Blood-brain barrier
    • Central nervous system
    • Cognition
    • Cognitive dysfunction
    • Cognitive impairment
    • Dementia
    • Neuroimaging
    • SLE
    • Systemic lupus erythematosus

    Fingerprint

    Dive into the research topics of 'Cognitive dysfunction and antiphospholipid antibodies'. Together they form a unique fingerprint.

    Cite this